Tzu-Fei Wang Selected Research

Tzu-Fei Wang Research Topics

Disease

40	Neoplasms (Cancer) 07/2022 - 01/2012
19	Hemorrhage 04/2022 - 02/2018
18	Venous Thromboembolism 10/2022 - 02/2018
13	Thrombosis (Thrombus) 04/2022 - 12/2016
5	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 01/2020
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 01/2020
3	Thromboembolism 01/2022 - 12/2019
3	Pulmonary Embolism 01/2022 - 04/2015
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2021 - 08/2018
3	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 10/2018
3	Thrombocytopenia (Thrombopenia) 12/2020 - 10/2018
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2022 - 12/2018
2	Atrial Fibrillation 01/2021 - 01/2019
2	Obesity 01/2020 - 09/2015
2	Multiple Myeloma 11/2016 - 02/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2022
1	Postthrombotic Syndrome 04/2022
1	Morbid Obesity 01/2022
1	Factor V Deficiency 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Stroke (Strokes) 01/2022
1	Chronic Disease (Chronic Diseases) 11/2021
1	Thrombophilia 01/2021
1	Upper Extremity Deep Vein Thrombosis 01/2021
1	Disseminated Intravascular Coagulation 12/2020
1	Leukemia 12/2020
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2020
1	Hemophilia A (Haemophilia) 12/2018
1	Body Weight (Weight, Body) 02/2018
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2017
1	Plasmacytoma 09/2012

Drug/Important Bio-Agent (IBA)

23	AnticoagulantsIBA 03/2022 - 09/2015
9	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021 - 02/2018
7	apixabanIBA 01/2022 - 12/2018
6	edoxabanIBA 12/2021 - 02/2018
5	Dalteparin (Dalteparin Sodium)FDA Link 12/2021 - 02/2018
4	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 01/2017
3	Vitamin K FDA Link 01/2022 - 01/2017
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2022 - 01/2022
2	Pharmaceutical PreparationsIBA 03/2022 - 01/2022
2	Hemoglobins (Hemoglobin)IBA 12/2021 - 01/2017
2	ORALIT (ORS)IBA 12/2021 - 11/2021
2	Immune Checkpoint InhibitorsIBA 09/2021 - 01/2020
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 11/2016
2	Asparaginase (Elspar)FDA Link 12/2020 - 01/2020
2	AntithrombinsIBA 01/2020 - 12/2019
1	Trinitrotoluene (TNT)IBA 07/2022
1	pro-brain natriuretic peptide (1-76)IBA 07/2022
1	Troponin T (Troponin T1)IBA 07/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2022
1	Biomarkers (Surrogate Marker)IBA 07/2022
1	Verapamil (Calan)FDA LinkGeneric 03/2022
1	Amiodarone (Amiodarona)FDA LinkGeneric 03/2022
1	Amlodipine (Norvasc)FDA LinkGeneric 03/2022
1	Metoprolol (Toprol-XL)FDA LinkGeneric 03/2022
1	Diltiazem (Cardizem)FDA LinkGeneric 03/2022
1	Cytochrome P-450 CYP3AIBA 03/2022
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022
1	Aromatase InhibitorsIBA 01/2022
1	Tamoxifen FDA LinkGeneric 01/2022
1	EnzymesIBA 01/2022
1	RivaroxabanIBA 05/2021
1	Factor Xa InhibitorsIBA 01/2021
1	Atorvastatin (Lipitor)FDA Link 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 12/2020
1	Hemostatics (Antihemorrhagics)IBA 12/2020
1	pegaspargase (Oncaspar)FDA Link 09/2020
1	AgglutininsIBA 01/2020
1	AntigensIBA 01/2020
1	AntibodiesIBA 01/2020
1	pembrolizumabIBA 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 12/2019
1	bivalirudin (Angiomax)FDA Link 12/2019
1	ibrutinibIBA 11/2019
1	3'-(1-butylphosphoryl)adenosineIBA 12/2018
1	Aminocaproic Acid (6 Aminocaproic Acid)FDA LinkGeneric 10/2018
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2016
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 11/2016
1	Oxidoreductases (Dehydrogenase)IBA 11/2016
1	NitrogenIBA 11/2016
1	Diphosphonates (Bisphosphonates)IBA 11/2016
1	carfilzomibIBA 02/2014
1	pomalidomideIBA 02/2014
1	Bortezomib (Velcade)FDA Link 02/2014
1	Lenalidomide (CC 5013)FDA Link 02/2014
1	afliberceptIBA 01/2012

Therapy/Procedure

13	Therapeutics 01/2022 - 06/2019
12	Drug Therapy (Chemotherapy) 10/2022 - 01/2012
5	Central Venous Catheters 01/2022 - 10/2018
3	Catheters 04/2022 - 01/2021
2	Duration of Therapy 08/2018 - 02/2018
1	Platelet Transfusion (Blood Platelet Transfusions) 12/2020
1	Bariatric Surgery 01/2020
1	Secondary Prevention 11/2019
1	Thrombolytic Therapy 04/2015
1	Transplantation 09/2012